GlassScriptPhysician profile
Jill K Stepnicka
NPI 1902807910
$3,963.60
in general payments reported to CMS, 2019-2025
14 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $52.26 · 2021: $5.40 · 2022: $304 · 2024: $976 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,757 · Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,756.83 |
| Food and Beverage | $772.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,916.96 | 2024-2025 | Motoband |
| Osteomed LLC | $1,018.48 | 2019 | |
| Depuy Synthes Sales INC. | $246.77 | 2024-2025 | Motoband, Na, Minibunion |
| Nevro Corp. | $153.73 | 2022 | |
| Ossio INC | $150.00 | 2022 | |
| Medtronic, INC. | $143.09 | 2024-2025 | Hawkone, Venaseal |
| Paratek Pharmaceuticals, INC. | $112.14 | 2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $94.16 | 2019-2020 | |
| Smith+Nephew, INC. | $47.71 | 2025 | Grafix, Grafix Pl, Grafix Xc |
| Acera Surgical, INC. | $23.77 | 2025 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $21.68 | 2025 | |
| Mimedx Group, INC. | $16.84 | 2024 | |
| Zimmer Biomet Holdings, INC. | $12.87 | 2019 | |
| Orthofix Medical, INC. | $5.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Stepnicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.